The patient's blood is drawn into the sterile device with no additives.
The LeucoPatch is prepared by a two step centrifugation in 20 minutes.
LeucoPatch is applied directly to the surface of the patient's wound.
The LeucoPatch device is composed of precision molded medical grade plastic components, that facilitates a unique processing of autologous blood.The LeucoPatch Device is approved for the EU market (CE-marked)
Although the creational process is remarkably simple, the LeucoPatch provides a biologically multifaceted product comprising three layers, providing wound coverage, growth factors and autologous cells to the wound.
Diabetes is a condition you learn to live with, but a foot ulcer is different because it heavily affects your daily life. Now that the wounds have healed I can lead a normal life again, so it means a great deal for me.
Dorthe H. Larsen, Denmark
There is nothing I would rather do than help my patients, and it's terrible not to be able to do anything further for them when their wounds won't heal. LeucoPatch creates hope both for me as a nurse and my patients.
Lisbeth Vorbeck, Nurse, Copenhagen Wound Healing Center, Denmark
We have a great need for new approaches to the treatment of diabetic foot ulcers. LeucoPatch is interesting because it is simple, logical and high-tech. We expect a lot of the large international randomised trial.
Bo Jørgensen, Doctor, Copenhagen Wound Healing Center, Denmark